Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koontz

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Clinical Microbiology|June 29, 2002
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithmS S Richter, S E Beekmann, J L Croco, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1994
Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus speciesT M Perl, P R Rhomberg, M J Bale, et al.
Cancer|August 15, 1991
High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinomaD A Rushing, W R Friedenberg, M C Baldauf, et al.
The Journal of Pediatrics|July 1, 1986
Effects of environmental warming on blood components dispensed in syringes for neonatal transfusionsR G Strauss, E F Bell, E L Snyder, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1992
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|February 1, 1991
Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetanR N Jones, E H Gerlach, F P Koontz, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Clinical Microbiology|June 29, 2002
Minimizing the workup of blood culture contaminants: implementation and evaluation of a laboratory-based algorithmS S Richter, S E Beekmann, J L Croco, et al.
Journal of Clinical Microbiology|January 1, 1992
MIC quality control guidelines for Haemophilus susceptibility tests using cefdinir (FK482), cefepime, cefetamet, cefpirome, ceftibuten, fleroxacin, temafloxacin, clarithromycin, RP59500, and trospectomycinM J Bale, R N Jones, M E Erwin, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1994
Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus speciesT M Perl, P R Rhomberg, M J Bale, et al.
Cancer|August 15, 1991
High-dose carmustine and autologous bone marrow reinfusion in the treatment of refractory or relapsed small cell lung carcinomaD A Rushing, W R Friedenberg, M C Baldauf, et al.
The Journal of Pediatrics|July 1, 1986
Effects of environmental warming on blood components dispensed in syringes for neonatal transfusionsR G Strauss, E F Bell, E L Snyder, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1991
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolatesP R Murray, S D Allen, M E Erwin, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1991
In vitro comparison of GR69153, a novel catechol-substituted cephalosporin, with ceftazidime and ceftriaxone against 5,203 recent clinical isolatesJ A Washington, R N Jones, S D Allen, et al.
Diagnostic Microbiology and Infectious Disease|September 1, 1991
Development of Neisseria gonorrhoeae in vitro susceptibility test methods for cefixime including quality control guidelinesR N Jones, E H Gerlach, F P Koontz, et al.
Diagnostic Microbiology and Infectious Disease|August 1, 1992
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelinesE H Gerlach, R N Jones, S D Allen, et al.
Journal of Clinical Microbiology|February 1, 1991
Interpretive criteria and quality control guidelines for Neisseria gonorrhoeae susceptibility test standardization for cefotetanR N Jones, E H Gerlach, F P Koontz, et al.
Pageof 6